Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y
Department of Internal Medicine, Sasebo Chuou Hospital, Sasebo City, Japan.
Diabetes Care. 1997 Oct;20(10):1562-8. doi: 10.2337/diacare.20.10.1562.
To investigate the relative contributions of insulin secretion and insulin resistance to the development of glucose intolerance in Japanese subjects.
A cross-sectional study of 756 Japanese subjects (530 nonobese, 226 obese) was performed. A 75-g oral glucose tolerance test (OGTT) was given, and subjects were classified according to the World Health Organization (WHO) criteria (normal glucose tolerance [NGT], impaired glucose tolerance [IGT], and diabetes). Early-phase insulin secretion was assessed by the insulinogenic index (the ratio of the increment of insulin to that of plasma glucose [PG] 30 min after a glucose load [delta IRI0-30 min/delta PG0-30 min]). Total insulin secretion was assessed by mean immunoreactive insulin (IRI) during the OGTT, and insulin resistance was assessed by use of the homeostasis model [HOMA(R)].
Early-phase insulin secretion was significantly decreased in IGT, compared with patients with NGT, in both the nonobese and obese subjects (0.70 +/- 0.05 vs. 0.37 +/- 0.03, P < 0.01 and 1.36 +/- 0.19 vs. 0.73 +/- 0.08, P < 0.01, respectively). However, mean IRI and HOMA(R) in both nonobese and obese subjects with IGT and NGT were not statistically different. Subjects with diabetes showed a significant decline in early-phase and total insulin secretion and a significantly higher level of insulin resistance than did subjects with IGT. When the fasting glucose (FPG) exceeded 100 mg/dl, early-phase insulin decreased progressively. The graphed relationship between FPG and mean IRI did not show an inverted U-shape, and mean IRI decreased progressively when FPG exceeded 100-130 mg/dl. The pattern of changes in insulin secretion and insulin resistance associated with the progression of glucose intolerance was similar in both the nonobese and obese subjects.
The worsening from NGT to IGT in Japanese subjects may be associated with a decrease in early-phase insulin secretion in nonobese as well as in obese subjects. Hyperinsulinemia in IGT is not common. We suggest that impaired early-phase insulin secretion may be the initial abnormality in the development of glucose intolerance in Japanese people. Insulin resistance may be a consequence of hyperglycemia and/or obesity.
探讨胰岛素分泌和胰岛素抵抗对日本受试者糖耐量异常发展的相对影响。
对756名日本受试者(530名非肥胖者,226名肥胖者)进行了一项横断面研究。进行了75克口服葡萄糖耐量试验(OGTT),并根据世界卫生组织(WHO)标准(正常糖耐量[NGT]、糖耐量受损[IGT]和糖尿病)对受试者进行分类。通过胰岛素生成指数(葡萄糖负荷后30分钟胰岛素增量与血浆葡萄糖[PG]增量之比[δIRI0 - 30分钟/δPG0 - 30分钟])评估早期胰岛素分泌。通过OGTT期间的平均免疫反应性胰岛素(IRI)评估总胰岛素分泌,并使用稳态模型[HOMA(R)]评估胰岛素抵抗。
在非肥胖和肥胖受试者中,与NGT患者相比,IGT患者的早期胰岛素分泌均显著降低(分别为0.70±0.05对0.37±0.03,P<0.01;1.36±0.19对0.73±0.08,P<0.01)。然而,IGT和NGT的非肥胖和肥胖受试者的平均IRI和HOMA(R)在统计学上无差异。糖尿病患者的早期和总胰岛素分泌显著下降,且胰岛素抵抗水平显著高于IGT患者。当空腹血糖(FPG)超过100mg/dl时,早期胰岛素逐渐下降。FPG与平均IRI的关系图未显示倒U形,当FPG超过100 - 130mg/dl时,平均IRI逐渐下降。非肥胖和肥胖受试者中与糖耐量异常进展相关的胰岛素分泌和胰岛素抵抗变化模式相似。
日本受试者从NGT恶化为IGT可能与非肥胖和肥胖受试者早期胰岛素分泌减少有关。IGT患者高胰岛素血症并不常见。我们认为,早期胰岛素分泌受损可能是日本人糖耐量异常发展的初始异常。胰岛素抵抗可能是高血糖和/或肥胖的结果。